Learning Objectives:
1. Understand the mechanisms involved in lupus skin inflammation.
2. Understand how type I interferons can impact predisposition to skin inflammation.
3. Predict how emerging therapies may impact skin inflammation in lupus patients.
Session date:
12/17/2019 - 8:30am to 9:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
J. Michelle Kahlenberg, M.D., Ph.D.